Hledání článků
Filtry
Frank Ch, Werber D, Cramer JP, et al., for the HUS Investigation Team. Epidemic profile of Shiga‑toxin‑producing Escherichia coli O104:H4 outbreak in Germany. N Engl J Med 2011;365:1771–1780.
Cruzado JM, Poveda R, Ibernón M, et al. Low‑dose sirolimus combined with angiotensin‑converting enzyme inhibitor and statin stabilizes renal function and reduces glomerular proliferation in poor prognosis IgA nephropathy. Nephol Dial Transplant 2011;26:3596–3602.
Rovin BH, Furie R, Latinis K, et al. Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The LUpus Nephritis Assessment with Rituximab (LUNAR) Study. Arthritis Rheum 2012; e‑pub ahead of print.
Foley RN, Gilbertson DT, Murray T, et al. Long interdialytic interval and mortality among patients receiving hemodialysis. N Engl J Med 2011; 365:1099–1107.
Hecking M, Karaboyas A, Saran R, Sen A, Hörl WH, Pisoni RL, Robinson BM, Sunder‑Plassmann G, Port FK. Predialysis serum sodium level, dialysate sodium, and mortality in maintenance hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2012;59:238–248.
Kopple JD, Cheung AK, Christiansen JS, et al. OPPORTUNITY™: a large‑scale randomized clinical trial of growth hormone in hemodialysis patients. Nephrol Dial Transplant 2011;26:4095–4103.
Westenfeld R, Schlieper G, Woltje M, et al. Impact of sirolimus, tacrolimus and mycophenolate mofetil on osteoclastogenesis – implications for post‑transplant bone disease. Nephrol Dial Transplant 2011;26:4115–4123.
Choukroun G, Kamar N, Dussol B, et al., for the CAPRIT study Investigators. Correction of postkidney transplant anemia reduces progression of allograft nephropathy. J Am Soc Nephrol 2012;23:360–368.
Bolée G, Flaman M, Schordan S, et al. Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis. Nat Med 2011; doi:10.1038/nm.2491
Dooley MA, Jayne D, Ginzler EM, et al. Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis. N Engl J Med 2011;365:1886–1895.
Siddiqi L, Oey PL, Blankestijn PJ. Akiskiren reduces sympathetic nerve aktivity and blood pressure in chronic kidney disease patiens. Nephrol Dial Transpl 2011;26:2930–2934.
Blankestijn PE, Ritz E. Renal denervation:potential impact on hypertension in kidney disease. Nephrol Dial Transpl 2011;26:2732–2734.
Kovesdy CP, Molnár MZ, Czira ME, et al. Diagnostic accuracy of serum parathyroid hormone levels in kidney transplant recipients with moderate‑to‑advanced CKD. Nephron Clin Pract 2011;118:c78–c85.